Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MREO |
---|---|---|
09:32 ET | 424 | 2.75 |
09:36 ET | 100 | 2.71 |
09:38 ET | 500 | 2.7103 |
09:39 ET | 693 | 2.72 |
09:41 ET | 400 | 2.725 |
09:45 ET | 300 | 2.73 |
09:50 ET | 2567 | 2.75 |
09:54 ET | 100 | 2.745 |
09:56 ET | 200 | 2.75 |
09:57 ET | 5041 | 2.775 |
09:59 ET | 1200 | 2.775 |
10:01 ET | 18442 | 2.8 |
10:03 ET | 8528 | 2.805 |
10:06 ET | 12929 | 2.855 |
10:08 ET | 39733 | 2.88 |
10:10 ET | 3136 | 2.87 |
10:12 ET | 34520 | 2.855 |
10:14 ET | 6296 | 2.865 |
10:15 ET | 9760 | 2.85 |
10:17 ET | 4400 | 2.85 |
10:19 ET | 536 | 2.84 |
10:24 ET | 1063 | 2.845 |
10:26 ET | 2430 | 2.85 |
10:28 ET | 900 | 2.85 |
10:30 ET | 1100 | 2.855 |
10:32 ET | 100 | 2.855 |
10:33 ET | 400 | 2.855 |
10:35 ET | 1900 | 2.85 |
10:39 ET | 2653 | 2.8598 |
10:44 ET | 900 | 2.865 |
10:46 ET | 300 | 2.87 |
10:48 ET | 6942 | 2.8699 |
10:50 ET | 1500 | 2.8727 |
10:51 ET | 300 | 2.87 |
10:53 ET | 100 | 2.88 |
10:55 ET | 1200 | 2.878 |
10:57 ET | 200 | 2.88 |
11:00 ET | 100 | 2.88 |
11:02 ET | 2872 | 2.8797 |
11:08 ET | 500 | 2.875 |
11:09 ET | 100 | 2.875 |
11:11 ET | 183 | 2.88 |
11:18 ET | 850 | 2.8789 |
11:22 ET | 1100 | 2.8701 |
11:24 ET | 100 | 2.88 |
11:26 ET | 300 | 2.875 |
11:27 ET | 6560 | 2.905 |
11:29 ET | 8188 | 2.89 |
11:31 ET | 300 | 2.895 |
11:33 ET | 3797 | 2.9 |
11:38 ET | 4515 | 2.91 |
11:40 ET | 750 | 2.905 |
11:42 ET | 800 | 2.91 |
11:44 ET | 1500 | 2.905 |
11:45 ET | 100 | 2.905 |
11:54 ET | 8939 | 2.925 |
11:56 ET | 12202 | 2.925 |
11:58 ET | 16000 | 2.94 |
12:00 ET | 200 | 2.945 |
12:02 ET | 3188 | 2.945 |
12:05 ET | 10700 | 2.9425 |
12:07 ET | 3742 | 2.955 |
12:09 ET | 1700 | 2.955 |
12:12 ET | 2200 | 2.96 |
12:14 ET | 8738 | 2.9611 |
12:16 ET | 2100 | 2.97 |
12:18 ET | 500 | 2.9692 |
12:20 ET | 127364 | 2.9775 |
12:21 ET | 23878 | 3.0025 |
12:23 ET | 30035 | 3.0166 |
12:25 ET | 6958 | 2.9975 |
12:27 ET | 1200 | 2.9991 |
12:30 ET | 2000 | 3 |
12:32 ET | 8896 | 2.9999 |
12:34 ET | 46015 | 3.005 |
12:36 ET | 6550 | 3 |
12:38 ET | 55571 | 2.995 |
12:39 ET | 8983 | 3 |
12:41 ET | 4315 | 3.01 |
12:43 ET | 88167 | 3.0017 |
12:45 ET | 91302 | 2.945 |
12:48 ET | 12891 | 2.935 |
12:50 ET | 9439 | 2.95 |
12:52 ET | 12049 | 2.95 |
12:54 ET | 5659 | 2.95 |
12:56 ET | 16928 | 2.97 |
12:57 ET | 6525 | 2.96 |
12:59 ET | 3272 | 2.97 |
01:01 ET | 12816 | 2.955 |
01:03 ET | 7519 | 2.97 |
01:06 ET | 28324 | 2.99 |
01:08 ET | 5505 | 2.985 |
01:10 ET | 9000 | 2.97 |
01:12 ET | 600 | 2.975 |
01:14 ET | 3070 | 2.965 |
01:15 ET | 100 | 2.965 |
01:17 ET | 500 | 2.965 |
01:19 ET | 200 | 2.96 |
01:21 ET | 300 | 2.961 |
01:24 ET | 8797 | 2.96 |
01:26 ET | 500 | 2.958 |
01:28 ET | 5127 | 2.945 |
01:30 ET | 5024 | 2.945 |
01:32 ET | 4339 | 2.945 |
01:33 ET | 100 | 2.945 |
01:35 ET | 1550 | 2.95 |
01:37 ET | 16159 | 2.975 |
01:39 ET | 585 | 2.9769 |
01:42 ET | 400 | 2.97 |
01:44 ET | 300 | 2.975 |
01:48 ET | 100 | 2.975 |
01:50 ET | 6586 | 2.985 |
01:51 ET | 600 | 2.985 |
01:53 ET | 904 | 2.985 |
01:55 ET | 4511 | 2.995 |
01:57 ET | 11420 | 3 |
02:00 ET | 7600 | 3 |
02:02 ET | 2205 | 3.0018 |
02:04 ET | 350 | 3.0045 |
02:06 ET | 11821 | 3.015 |
02:08 ET | 4450 | 3.0172 |
02:09 ET | 8849 | 3.025 |
02:11 ET | 200 | 3.025 |
02:15 ET | 100 | 3.025 |
02:18 ET | 300 | 3.025 |
02:20 ET | 9550 | 3.035 |
02:22 ET | 430 | 3.035 |
02:24 ET | 1800 | 3.035 |
02:26 ET | 14427 | 3.02 |
02:27 ET | 727 | 3.025 |
02:29 ET | 200 | 3.025 |
02:31 ET | 1861 | 3.0222 |
02:33 ET | 9975 | 3.01 |
02:36 ET | 100 | 3.01 |
02:38 ET | 745 | 3.015 |
02:40 ET | 1170 | 3.015 |
02:44 ET | 11472 | 3.015 |
02:45 ET | 1425 | 3.02 |
02:47 ET | 202 | 3.015 |
02:49 ET | 1455 | 3.0115 |
02:51 ET | 100 | 3.01 |
02:54 ET | 126 | 3.005 |
02:56 ET | 5441 | 2.985 |
02:58 ET | 3300 | 2.985 |
03:00 ET | 2109 | 2.99 |
03:03 ET | 12461 | 3 |
03:05 ET | 200 | 3 |
03:07 ET | 200 | 3 |
03:09 ET | 700 | 2.995 |
03:12 ET | 2711 | 3.005 |
03:14 ET | 1898 | 3.005 |
03:16 ET | 700 | 3.005 |
03:18 ET | 1926 | 3 |
03:20 ET | 3012 | 3.01 |
03:21 ET | 8575 | 3.02 |
03:23 ET | 23741 | 3.0382 |
03:25 ET | 1065 | 3.035 |
03:27 ET | 8995 | 3.04 |
03:30 ET | 3227 | 3.0401 |
03:32 ET | 7788 | 3.03 |
03:34 ET | 100 | 3.04 |
03:36 ET | 4898 | 3.045 |
03:38 ET | 2521 | 3.045 |
03:39 ET | 2002 | 3.05 |
03:41 ET | 3879 | 3.05 |
03:43 ET | 6349 | 3.05 |
03:45 ET | 4300 | 3.055 |
03:48 ET | 20891 | 3.05 |
03:50 ET | 4620 | 3.0679 |
03:52 ET | 21221 | 3.065 |
03:54 ET | 18984 | 3.085 |
03:56 ET | 7234 | 3.0799 |
03:57 ET | 12747 | 3.07 |
03:59 ET | 24089 | 3.05 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Mereo BioPharma Group PLC | 387.1M | -11.6x | --- |
Allogene Therapeutics Inc | 484.9M | -1.3x | --- |
Nkarta Inc | 485.7M | -2.8x | --- |
Humacyte Inc | 487.1M | -3.7x | --- |
Celcuity Inc | 488.8M | -5.8x | --- |
Cabaletta Bio Inc | 490.5M | -6.4x | --- |
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $387.1M |
---|---|
Revenue (TTM) | $9.0M |
Shares Outstanding | 140.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.82 |
EPS | $-0.26 |
Book Value | $0.62 |
P/E Ratio | -11.6x |
Price/Sales (TTM) | 43.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -444.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.